US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Generation Income Properties Inc.

0.5828

-0.0072-1.22%

Volume:3.50K

Turnover:2.06K

Market Cap:3.17M

PE:-0.31

High:0.5900

Open:0.5900

Low:0.5828

Close:0.5900

52wk High:2.06

52wk Low:0.5600

Shares:5.45M

Float Shares:4.48M

Volume Ratio:0.26

T/O Rate:0.08%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.8906

EPS(LYR):-1.6353

ROE:-20.80%

ROA:-0.63%

PB:-0.81

PE(LYR):-0.36

Loading ...

Overview Company News Filings

Nasdaq Moves to Delist Generation Income Properties Over Equity Rule Violation

Nasdaq Warns Generation Income Properties on Minimum Bid Price Compliance

1+1>2? INSILICO's (03696) GIPR Antagonist Combination Strategy Ignites the Next Weight Loss Trend

ASCLETIS-B (01672) Selects Next-Generation Monthly Subcutaneous GLP-1R/GIPR/GCGR Triple Agonist Peptide ASC37 for Clinical Development

Ascletis Selects a Next-Generation Once-Monthly Subcutaneously Administered GLP-1R/GIPR/GCGR Triple Peptide Agonist, ASC37, for Clinical Development

Generation Income Properties Inc Held Annual Shareholder Meeting

ASCLETIS-B (01672) Selects Its First Oral GLP-1R/GIPR/GCGR Triple-Target Agonist Peptide ASC37 for Clinical Development

Ascletis Selects Its First Oral GLP-1R/GIPR/GCGR Triple Peptide Agonist, ASC37, for Clinical Development

Generation Income Q3 FFO $0.03 Beats $(0.08) Estimate, Sales $2.470M Beat $2.432M Estimate

Generation Income Properties Reports Q3 2025 Financial and Operating Results

ASCLETIS-B (01672): Monthly-Dose Next-Gen Amylin Receptor Agonist ASC36 and GLP-1R/GIPR Dual-Target Agonist ASC35 Combo Advances to Clinical Development

Ascletis Announces Co-formulation of ASC36, Once-Monthly Next-Generation Amylin Receptor Agonist and ASC35, Once-Monthly Next-Generation GLP-1R/GIPR Dual Agonist for Clinical Development

Press Release: Terns Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Corporate Updates

Generation Income Properties Inc Announces Date for Upcoming Stockholder Meeting

Generation Income Properties Sells Vacant Florida Industrial Property for $1.95 Million

Generation Income Properties Extends Promissory Note Maturity to December 2025

Hengrui's Class 1 Innovative Drug HRS-4729, a GLP-1R/GIPR/GCGR Triple Receptor Agonist, Receives Clinical Trial Approval for Metabolic Associated Fatty Liver Disease/Metabolic Associated Steatohepatitis

Generation Income Properties Inc. Faces Potential Delisting from Nasdaq Due to Non-Compliance with Equity Requirements

David Sobelman, Chairman, President, and CEO, Reports Acquisition of Common Shares in Generation Income Properties Inc

Generation Income Properties Secures Early Lease Extension with Best Buy, Increasing Rent and Reinforcing Commitment

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/GIPR/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GIPR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GIPR\",,,,,undefined,":{"symbol":"GIPR","market":"US","secType":"STK","nameCN":"Generation Income Properties Inc.","latestPrice":0.5828,"timestamp":1770825745612,"preClose":0.59,"halted":0,"volume":3504,"delay":0,"changeRate":-0.012203389830508449,"floatShares":4482929,"shares":5447772,"eps":-1.890643,"marketStatus":"Trading","change":-0.0072,"latestTime":"02-11 11:07:53 EST","open":0.59,"high":0.59,"low":0.5828,"amount":2064.711852,"amplitude":0.012203,"askPrice":0.6097,"askSize":100,"bidPrice":0.56,"bidSize":17,"shortable":3,"etf":0,"ttmEps":-1.890643,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1770843600000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":0.59,"postHourTrading":{"tag":"盘后","latestPrice":0.59,"preClose":0.59,"latestTime":"16:35 EST","volume":9,"amount":5.3099,"timestamp":1770759313548,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.261854},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GIPR\",,,,,undefined,":{"symbol":"GIPR","floatShares":4482929,"roa":"-0.63%","roe":"-20.80%","lyrEps":-1.635274,"volumeRatio":0.261854,"shares":5447772,"dividePrice":0,"high":0.59,"amplitude":0.012203,"preClose":0.59,"low":0.5828,"week52Low":0.56,"pbRate":"-0.81","psRate":"0.32","week52High":2.0599,"institutionHeld":0,"latestPrice":0.5828,"committee":-0.709402,"eps":-1.890643,"divideRate":0,"volume":3504,"delay":0,"ttmEps":-1.890643,"open":0.59,"prevYearClose":0.641,"prevWeekClose":0.63,"prevMonthClose":0.696,"prevQuarterClose":0.641,"fiveDayClose":0.65,"twentyDayClose":0.8,"sixtyDayClose":1.03,"dividendFrequency":"M","dividendGrowthYears":0,"dividendGrowthRate":-0.5,"fiveYearAvgDividendRate":0.1268762189026118},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GIPR\",params:#limit:5,,,undefined,":[{"date":"2024-06-14","symbol":"GIPR","amount":0.039,"announcedDate":"2024-06-03","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-15","defaultRemindTime":1718371800000,"name":"Generation Income Properties Inc.","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-06-28","payableDate":"2024-06-15","currency":"USD","dateTimestamp":1718337600000,"payDate":"2024-06-28"},{"date":"2024-05-14","symbol":"GIPR","amount":0.039,"announcedDate":null,"type":"dividend","market":"US","newRecordDate":"2024-05-15","defaultRemindTime":1715693400000,"name":"Generation Income Properties Inc.","recordDate":"2024-05-30","payableDate":"2024-05-15","currency":"USD","dateTimestamp":1715659200000,"payDate":"2024-05-30"},{"date":"2024-04-12","symbol":"GIPR","amount":0.039,"announcedDate":"2024-04-04","type":"dividend","market":"US","newRecordDate":"2024-04-15","defaultRemindTime":1712928600000,"name":"Generation Income Properties Inc.","recordDate":"2024-04-30","payableDate":"2024-04-15","currency":"USD","dateTimestamp":1712894400000,"payDate":"2024-04-30"},{"date":"2024-03-14","symbol":"GIPR","amount":0.039,"announcedDate":"2024-01-05","type":"dividend","market":"US","newRecordDate":"2024-03-15","defaultRemindTime":1710423000000,"name":"Generation Income Properties Inc.","recordDate":"2024-03-29","payableDate":"2024-03-15","currency":"USD","dateTimestamp":1710388800000,"payDate":"2024-03-29"},{"date":"2024-02-14","symbol":"GIPR","amount":0.039,"announcedDate":"2024-01-04","type":"dividend","market":"US","newRecordDate":"2024-02-15","defaultRemindTime":1707921000000,"name":"Generation Income Properties Inc.","recordDate":"2024-02-29","payableDate":"2024-02-15","currency":"USD","dateTimestamp":1707886800000,"payDate":"2024-02-29"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GIPR\",market:\"US\",,,undefined,":[{"executeDate":"2020-11-16","recordDate":"2020-11-17","paymentDate":"2020-11-24","value":0.35,"currency":"USD"},{"executeDate":"2021-10-14","recordDate":"2021-10-15","paymentDate":"2021-10-30","value":0.054,"currency":"USD"},{"executeDate":"2021-11-12","recordDate":"2021-11-15","paymentDate":"2021-11-30","value":0.054,"currency":"USD"},{"executeDate":"2021-12-14","recordDate":"2021-12-15","paymentDate":"2021-12-30","value":0.054,"currency":"USD"},{"executeDate":"2022-01-13","recordDate":"2022-01-15","paymentDate":"2022-01-30","value":0.054,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GIPR\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":1,"updateTime":1717650000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/GIPR\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"GIPR","date":"2026-02-10","current":-0.308255,"percent":1,"low":-19.027309,"twenty":-8.125044,"median":-2.684937,"eighty":-0.971558,"high":-0.30276,"avg":-4.587766,"sd":4.757063,"marketCap":3110677},"quantilePoints":[{"date":"2021-09-03","current":-10.409151,"twenty":-10.409151,"median":-10.409151,"eighty":-10.409151,"marketCap":19703670},{"date":"2021-09-10","current":-10.145592,"twenty":-10.409151,"median":-10.409151,"eighty":-10.156667,"marketCap":19204773},{"date":"2021-09-17","current":-9.753374,"twenty":-10.409151,"median":-10.079598,"eighty":-9.910199,"marketCap":18462338},{"date":"2021-09-24","current":-9.763784,"twenty":-10.367514,"median":-9.99622,"eighty":-9.790598,"marketCap":18482042},{"date":"2021-10-01","current":-9.888694,"twenty":-10.190559,"median":-9.982376,"eighty":-9.764242,"marketCap":18718486},{"date":"2021-10-08","current":-7.307224,"twenty":-10.148256,"median":-9.888694,"eighty":-9.592783,"marketCap":13831976},{"date":"2021-10-15","current":-8.639596,"twenty":-10.119194,"median":-9.836648,"eighty":-8.743667,"marketCap":16354046},{"date":"2021-10-22","current":-7.249974,"twenty":-10.011521,"median":-9.763784,"eighty":-8.366876,"marketCap":13723606},{"date":"2021-10-29","current":-7.338452,"twenty":-10.001799,"median":-9.63544,"eighty":-7.783963,"marketCap":13891087},{"date":"2021-11-05","current":-7.182418,"twenty":-9.993451,"median":-9.159949,"eighty":-7.57578,"marketCap":13595729},{"date":"2021-11-12","current":-7.140678,"twenty":-9.982376,"median":-8.605766,"eighty":-7.434216,"marketCap":13516717},{"date":"2021-11-19","current":-15.966288,"twenty":-10.119194,"median":-9.159949,"eighty":-7.451911,"marketCap":14084517},{"date":"2021-11-26","current":-16.118359,"twenty":-10.409151,"median":-9.564345,"eighty":-7.489384,"marketCap":14218665},{"date":"2021-12-03","current":-16.284634,"twenty":-14.986761,"median":-9.758579,"eighty":-7.567453,"marketCap":14365343},{"date":"2021-12-10","current":-15.79487,"twenty":-15.5255,"median":-9.784602,"eighty":-7.609089,"marketCap":13933302},{"date":"2021-12-17","current":-14.668414,"twenty":-15.721405,"median":-9.888694,"eighty":-7.619499,"marketCap":12939609},{"date":"2021-12-23","current":-14.913296,"twenty":-15.682224,"median":-9.961558,"eighty":-7.627826,"marketCap":13155630},{"date":"2021-12-31","current":-15.25613,"twenty":-15.554886,"median":-9.99622,"eighty":-7.646562,"marketCap":13458058},{"date":"2022-01-07","current":-15.158178,"twenty":-15.466728,"median":-10.079598,"eighty":-7.750654,"marketCap":13371650},{"date":"2022-01-14","current":-16.627468,"twenty":-15.736098,"median":-10.200968,"eighty":-7.808946,"marketCap":14667771},{"date":"2022-01-21","current":-16.700932,"twenty":-16.010366,"median":-10.409151,"eighty":-7.985901,"marketCap":14732577},{"date":"2022-01-28","current":-17.14172,"twenty":-16.145688,"median":-12.36126,"eighty":-8.140414,"marketCap":15121414},{"date":"2022-02-04","current":-17.198532,"twenty":-16.284634,"median":-14.521485,"eighty":-8.263783,"marketCap":15171530},{"date":"2022-02-11","current":-17.362113,"twenty":-16.392381,"median":-14.705147,"eighty":-8.445985,"marketCap":15315832},{"date":"2022-02-18","current":-16.921326,"twenty":-16.686239,"median":-14.815344,"eighty":-8.543831,"marketCap":14926995},{"date":"2022-02-25","current":-17.117231,"twenty":-16.798885,"median":-14.986761,"eighty":-8.562568,"marketCap":15099811},{"date":"2022-03-04","current":-18.096758,"twenty":-16.896837,"median":-15.121446,"eighty":-8.599,"marketCap":15963892},{"date":"2022-03-11","current":-18.49518,"twenty":-17.108807,"median":-15.182666,"eighty":-8.847737,"marketCap":16315357},{"date":"2022-03-18","current":-12.2189,"twenty":-17.131924,"median":-15.219398,"eighty":-9.159949,"marketCap":14980542},{"date":"2022-03-25","current":-12.541867,"twenty":-17.117231,"median":-15.158178,"eighty":-9.2849,"marketCap":15376504},{"date":"2022-04-01","current":-12.990431,"twenty":-17.108807,"median":-15.011249,"eighty":-9.509134,"marketCap":15926450},{"date":"2022-04-08","current":-12.380383,"twenty":-17.07521,"median":-14.815344,"eighty":-9.621221,"marketCap":15178523},{"date":"2022-04-14","current":-12.659391,"twenty":-17.019278,"median":-14.717391,"eighty":-9.715902,"marketCap":15520590},{"date":"2022-04-22","current":-13.178828,"twenty":-16.916428,"median":-14.59495,"eighty":-9.755456,"marketCap":16157428},{"date":"2022-04-29","current":-12.760429,"twenty":-16.896837,"median":-14.105186,"eighty":-9.764242,"marketCap":15644465},{"date":"2022-05-06","current":-12.687093,"twenty":-16.896837,"median":-13.214713,"eighty":-9.76978,"marketCap":15554554},{"date":"2022-05-13","current":-11.101634,"twenty":-16.891939,"median":-13.080143,"eighty":-9.80542,"marketCap":14992612},{"date":"2022-05-20","current":-10.649736,"twenty":-16.857656,"median":-12.951854,"eighty":-9.888694,"marketCap":14382330},{"date":"2022-05-27","current":-11.249722,"twenty":-16.798885,"median":-12.882775,"eighty":-9.888694,"marketCap":15192603},{"date":"2022-06-03","current":-11.420884,"twenty":-16.798885,"median":-12.791448,"eighty":-9.888694,"marketCap":15423755},{"date":"2022-06-10","current":-11.083059,"twenty":-16.749908,"median":-12.751262,"eighty":-9.940739,"marketCap":14967527},{"date":"2022-06-17","current":-10.349743,"twenty":-16.700932,"median":-12.721378,"eighty":-9.982376,"marketCap":13977194},{"date":"2022-06-24","current":-10.449741,"twenty":-16.681342,"median":-12.687093,"eighty":-9.982376,"marketCap":14112240},{"date":"2022-07-01","current":-10.620237,"twenty":-16.656854,"median":-12.654908,"eighty":-9.993451,"marketCap":14342492},{"date":"2022-07-08","current":-11.333052,"twenty":-16.637263,"median":-12.631579,"eighty":-10.000404,"marketCap":15305140},{"date":"2022-07-15","current":-10.502907,"twenty":-16.495232,"median":-12.541867,"eighty":-10.009439,"marketCap":14184039},{"date":"2022-07-22","current":-10.393076,"twenty":-16.392381,"median":-12.422151,"eighty":-10.065291,"marketCap":14035714},{"date":"2022-07-29","current":-10.279245,"twenty":-16.3532,"median":-12.380383,"eighty":-10.127255,"marketCap":13881987},{"date":"2022-08-05","current":-9.958087,"twenty":-16.304224,"median":-12.281699,"eighty":-10.009439,"marketCap":13448267},{"date":"2022-08-12","current":-6.662445,"twenty":-16.284634,"median":-12.2189,"eighty":-9.99704,"marketCap":13504536},{"date":"2022-08-19","current":-6.547752,"twenty":-16.269941,"median":-12.05634,"eighty":-9.982376,"marketCap":13272058},{"date":"2022-08-26","current":-6.570061,"twenty":-16.260145,"median":-11.483049,"eighty":-9.888694,"marketCap":13317278},{"date":"2022-09-02","current":-7.897459,"twenty":-16.230759,"median":-11.361968,"eighty":-9.777191,"marketCap":16007865},{"date":"2022-09-09","current":-8.042469,"twenty":-16.201374,"median":-11.341386,"eighty":-9.72527,"marketCap":16301795},{"date":"2022-09-16","current":-7.529357,"twenty":-16.159352,"median":-11.286054,"eighty":-9.159949,"marketCap":15261736},{"date":"2022-09-23","current":-7.038555,"twenty":-16.116302,"median":-11.258055,"eighty":-8.537586,"marketCap":14266897},{"date":"2022-09-30","current":-6.703916,"twenty":-16.083831,"median":-11.134922,"eighty":-8.116136,"marketCap":13588597},{"date":"2022-10-07","current":-6.185227,"twenty":-16.039752,"median":-11.074725,"eighty":-7.935385,"marketCap":12537233},{"date":"2022-10-14","current":-5.543838,"twenty":-16.020162,"median":-10.991394,"eighty":-7.765071,"marketCap":11237160},{"date":"2022-10-21","current":-5.521529,"twenty":-15.980981,"median":-10.933063,"eighty":-7.638235,"marketCap":11191940},{"date":"2022-10-28","current":-5.833857,"twenty":-15.897721,"median":-10.683068,"eighty":-7.578986,"marketCap":11825019},{"date":"2022-11-04","current":-5.633074,"twenty":-15.765484,"median":-10.666403,"eighty":-7.473212,"marketCap":11418039},{"date":"2022-11-11","current":-5.694425,"twenty":-15.701815,"median":-10.666403,"eighty":-7.432134,"marketCap":11542394},{"date":"2022-11-18","current":-3.998946,"twenty":-15.613657,"median":-10.649736,"eighty":-7.306649,"marketCap":12482450},{"date":"2022-11-25","current":-4.062929,"twenty":-15.510807,"median":-10.63307,"eighty":-7.255179,"marketCap":12682169},{"date":"2022-12-02","current":-4.118834,"twenty":-15.447137,"median":-10.617334,"eighty":-7.13235,"marketCap":12856673},{"date":"2022-12-09","current":-3.886975,"twenty":-15.417752,"median":-10.50549,"eighty":-6.985013,"marketCap":12132941},{"date":"2022-12-16","current":-3.878977,"twenty":-15.376122,"median":-10.483074,"eighty":-6.723838,"marketCap":12107976},{"date":"2022-12-23","current":-3.98295,"twenty":-15.354083,"median":-10.473073,"eighty":-6.603525,"marketCap":12432520},{"date":"2022-12-30","current":-3.87098,"twenty":-15.305107,"median":-10.458074,"eighty":-6.547752,"marketCap":12083011},{"date":"2023-01-06","current":-3.918967,"twenty":-15.265925,"median":-10.41278,"eighty":-6.460746,"marketCap":12232801},{"date":"2023-01-13","current":-4.100759,"twenty":-15.197359,"median":-10.409151,"eighty":-6.346969,"marketCap":12800253},{"date":"2023-01-20","current":-4.078925,"twenty":-15.182666,"median":-10.383076,"eighty":-5.878476,"marketCap":12732099},{"date":"2023-01-27","current":-3.90785,"twenty":-15.167973,"median":-10.306161,"eighty":-5.789239,"marketCap":12198099},{"date":"2023-02-03","current":-3.950958,"twenty":-15.114099,"median":-10.200968,"eighty":-5.688847,"marketCap":12332660},{"date":"2023-02-10","current":-4.85472,"twenty":-15.055327,"median":-10.170418,"eighty":-5.633074,"marketCap":15153694},{"date":"2023-02-17","current":-4.638777,"twenty":-15.006351,"median":-10.09975,"eighty":-5.539376,"marketCap":14479642},{"date":"2023-02-24","current":-4.302866,"twenty":-14.957375,"median":-10.058084,"eighty":-5.465756,"marketCap":13431116},{"date":"2023-03-03","current":-4.462824,"twenty":-14.874115,"median":-10.001473,"eighty":-5.354701,"marketCap":13930414},{"date":"2023-03-10","current":-4.102918,"twenty":-14.805548,"median":-9.99622,"eighty":-4.62918,"marketCap":12806993},{"date":"2023-03-17","current":-3.878977,"twenty":-14.761469,"median":-9.982731,"eighty":-4.51401,"marketCap":12107976},{"date":"2023-03-24","current":-3.823072,"twenty":-14.707596,"median":-9.958087,"eighty":-4.398841,"marketCap":11933471},{"date":"2023-03-31","current":-3.628872,"twenty":-14.683107,"median":-9.888694,"eighty":-4.346054,"marketCap":11748982},{"date":"2023-04-06","current":-3.564359,"twenty":-14.668414,"median":-9.888694,"eighty":-4.270874,"marketCap":11540111},{"date":"2023-04-14","current":-3.524038,"twenty":-14.521485,"median":-9.775338,"eighty":-4.174899,"marketCap":11409567},{"date":"2023-04-21","current":-3.548231,"twenty":-14.301091,"median":-9.753374,"eighty":-4.158904,"marketCap":11487894},{"date":"2023-04-28","current":-3.494362,"twenty":-14.105186,"median":-9.518336,"eighty":-4.102918,"marketCap":11313486},{"date":"2023-05-05","current":-3.379872,"twenty":-13.38139,"median":-9.159949,"eighty":-4.078925,"marketCap":10942809},{"date":"2023-05-12","current":-3.552173,"twenty":-13.241627,"median":-8.564129,"eighty":-4.070927,"marketCap":11500657},{"date":"2023-05-19","current":-2.887445,"twenty":-13.1878,"median":-8.327321,"eighty":-4.05893,"marketCap":11491255},{"date":"2023-05-26","current":-2.793503,"twenty":-13.178828,"median":-8.12059,"eighty":-4.046933,"marketCap":11117392},{"date":"2023-06-02","current":-2.701482,"twenty":-13.09988,"median":-8.009005,"eighty":-4.02134,"marketCap":10751172},{"date":"2023-06-09","current":-2.642326,"twenty":-13.029712,"median":-7.930923,"eighty":-4.005344,"marketCap":10515745},{"date":"2023-06-16","current":-2.648898,"twenty":-13.0011,"median":-7.817273,"eighty":-3.995747,"marketCap":10541903},{"date":"2023-06-23","current":-2.585207,"twenty":-12.959569,"median":-7.758027,"eighty":-3.98295,"marketCap":10288427},{"date":"2023-06-30","current":-2.596315,"twenty":-12.908504,"median":-7.707831,"eighty":-3.971753,"marketCap":10332635},{"date":"2023-07-07","current":-2.576596,"twenty":-12.889414,"median":-7.629908,"eighty":-3.962955,"marketCap":10254159},{"date":"2023-07-14","current":-2.73106,"twenty":-12.882775,"median":-7.602687,"eighty":-3.918967,"marketCap":10868885},{"date":"2023-07-21","current":-2.688336,"twenty":-12.833765,"median":-7.529357,"eighty":-3.902971,"marketCap":10698855},{"date":"2023-07-28","current":-2.74092,"twenty":-12.791448,"median":-7.475907,"eighty":-3.878977,"marketCap":10908123},{"date":"2023-08-04","current":-2.687284,"twenty":-12.77512,"median":-7.44012,"eighty":-3.838988,"marketCap":10694669},{"date":"2023-08-11","current":-2.67519,"twenty":-12.760429,"median":-7.385293,"eighty":-3.822992,"marketCap":10646537},{"date":"2023-08-18","current":-2.539207,"twenty":-12.742095,"median":-7.307224,"eighty":-3.778444,"marketCap":9685337},{"date":"2023-08-25","current":-2.470513,"twenty":-12.723761,"median":-7.285554,"eighty":-3.665161,"marketCap":9423316},{"date":"2023-09-01","current":-2.573452,"twenty":-12.721378,"median":-7.183565,"eighty":-3.620808,"marketCap":9815955},{"date":"2023-09-08","current":-2.642077,"twenty":-12.721309,"median":-7.140678,"eighty":-3.561922,"marketCap":10077713},{"date":"2023-09-15","current":-2.855252,"twenty":-12.693933,"median":-7.12903,"eighty":-3.548231,"marketCap":10890830},{"date":"2023-09-22","current":-2.683662,"twenty":-12.672426,"median":-6.971627,"eighty":-3.528864,"marketCap":10236333},{"date":"2023-09-29","current":-2.697389,"twenty":-12.663138,"median":-6.804308,"eighty":-3.494168,"marketCap":10288692},{"date":"2023-10-06","current":-2.684937,"twenty":-12.654012,"median":-6.683181,"eighty":-3.480834,"marketCap":10241197},{"date":"2023-10-13","current":-2.72607,"twenty":-12.639118,"median":-6.603525,"eighty":-3.408911,"marketCap":10398089},{"date":"2023-10-20","current":-2.684937,"twenty":-12.631579,"median":-6.567384,"eighty":-2.932069,"marketCap":10241197},{"date":"2023-10-27","current":-2.623136,"twenty":-12.631579,"median":-6.55623,"eighty":-2.887445,"marketCap":10005466},{"date":"2023-11-03","current":-2.664543,"twenty":-12.541867,"median":-6.46967,"eighty":-2.86854,"marketCap":10163405},{"date":"2023-11-10","current":-2.698671,"twenty":-12.541867,"median":-6.419474,"eighty":-2.841525,"marketCap":10293581},{"date":"2023-11-17","current":-2.176212,"twenty":-12.470455,"median":-6.369278,"eighty":-2.787665,"marketCap":10476928},{"date":"2023-11-24","current":-2.17644,"twenty":-12.436518,"median":-6.185227,"eighty":-2.760259,"marketCap":10478028},{"date":"2023-12-01","current":-2.160116,"twenty":-12.418621,"median":-5.839434,"eighty":-2.746232,"marketCap":10399442},{"date":"2023-12-08","current":-2.171053,"twenty":-12.38957,"median":-5.800394,"eighty":-2.736976,"marketCap":10452094},{"date":"2023-12-15","current":-2.213657,"twenty":-12.380885,"median":-5.71969,"eighty":-2.732648,"marketCap":10657202},{"date":"2023-12-22","current":-2.115935,"twenty":-12.322966,"median":-5.688847,"eighty":-2.728175,"marketCap":10186738},{"date":"2023-12-29","current":-2.170999,"twenty":-12.301435,"median":-5.652929,"eighty":-2.726752,"marketCap":10451832},{"date":"2024-01-05","current":-2.132911,"twenty":-12.29067,"median":-5.633074,"eighty":-2.721201,"marketCap":10268467},{"date":"2024-01-12","current":-2.285262,"twenty":-12.272728,"median":-5.549416,"eighty":-2.712405,"marketCap":11001929},{"date":"2024-01-19","current":-2.162837,"twenty":-12.244019,"median":-5.53826,"eighty":-2.701482,"marketCap":10412540},{"date":"2024-01-26","current":-2.210438,"twenty":-12.222488,"median":-5.49922,"eighty":-2.698415,"marketCap":10641705},{"date":"2024-02-02","current":-2.154823,"twenty":-12.204546,"median":-5.428109,"eighty":-2.688336,"marketCap":10373956},{"date":"2024-02-09","current":-1.919275,"twenty":-12.129187,"median":-5.35421,"eighty":-2.684937,"marketCap":9239961},{"date":"2024-02-16","current":-1.941085,"twenty":-12.023398,"median":-4.702761,"eighty":-2.684682,"marketCap":9344960},{"date":"2024-02-23","current":-1.652103,"twenty":-11.780401,"median":-4.610785,"eighty":-2.681763,"marketCap":7953716},{"date":"2024-03-01","current":-1.717533,"twenty":-11.543047,"median":-4.542803,"eighty":-2.669537,"marketCap":8268715},{"date":"2024-03-08","current":-1.935633,"twenty":-11.44575,"median":-4.470822,"eighty":-2.662044,"marketCap":9318710},{"date":"2024-03-15","current":-2.066492,"twenty":-11.392884,"median":-4.382845,"eighty":-2.654897,"marketCap":9948708},{"date":"2024-03-22","current":-2.10466,"twenty":-11.359519,"median":-4.354852,"eighty":-2.647704,"marketCap":10132457},{"date":"2024-03-28","current":-2.033777,"twenty":-11.349719,"median":-4.32286,"eighty":-2.642326,"marketCap":9791208},{"date":"2024-04-05","current":-2.052861,"twenty":-11.343052,"median":-4.254878,"eighty":-2.636568,"marketCap":9883083},{"date":"2024-04-12","current":-1.717161,"twenty":-11.319719,"median":-4.190895,"eighty":-2.623136,"marketCap":9817458},{"date":"2024-04-19","current":-3.602148,"twenty":-11.294254,"median":-4.166901,"eighty":-2.625554,"marketCap":20594426},{"date":"2024-04-26","current":-3.596176,"twenty":-11.284854,"median":-4.141868,"eighty":-2.62918,"marketCap":20560283},{"date":"2024-05-03","current":-3.592669,"twenty":-11.276388,"median":-4.102918,"eighty":-2.631809,"marketCap":20540230},{"date":"2024-05-10","current":-3.791735,"twenty":-11.259722,"median":-4.101838,"eighty":-2.636568,"marketCap":21678344},{"date":"2024-05-17","current":-4.15195,"twenty":-11.249722,"median":-4.102918,"eighty":-2.639505,"marketCap":23737786},{"date":"2024-05-24","current":-3.450573,"twenty":-11.203802,"median":-4.09784,"eighty":-2.642177,"marketCap":24930095},{"date":"2024-05-31","current":-3.248039,"twenty":-11.128264,"median":-4.08226,"eighty":-2.642326,"marketCap":23466807},{"date":"2024-06-07","current":-3.324627,"twenty":-11.097919,"median":-4.078925,"eighty":-2.642326,"marketCap":24020146},{"date":"2024-06-14","current":-3.106988,"twenty":-11.083059,"median":-4.070927,"eighty":-2.642326,"marketCap":22447721},{"date":"2024-06-21","current":-2.926872,"twenty":-11.069725,"median":-4.062929,"eighty":-2.642326,"marketCap":21146404},{"date":"2024-06-28","current":-3.106988,"twenty":-11.053059,"median":-4.062929,"eighty":-2.643043,"marketCap":22447721},{"date":"2024-07-05","current":-3.089201,"twenty":-10.999728,"median":-4.055491,"eighty":-2.645912,"marketCap":22319216},{"date":"2024-07-12","current":-2.904358,"twenty":-10.991394,"median":-4.046933,"eighty":-2.648898,"marketCap":20983739},{"date":"2024-07-15","current":-2.90811,"twenty":-10.989728,"median":-4.046933,"eighty":-2.648898,"marketCap":21010850},{"date":"2024-08-02","current":-1.921229,"twenty":-10.988061,"median":-4.042934,"eighty":-2.647106,"marketCap":13880716},{"date":"2024-08-09","current":-1.636047,"twenty":-10.969729,"median":-4.022939,"eighty":-2.642326,"marketCap":11820297},{"date":"2024-08-16","current":-1.288563,"twenty":-10.936396,"median":-4.008983,"eighty":-2.631809,"marketCap":11088306},{"date":"2024-08-23","current":-1.670094,"twenty":-10.883064,"median":-3.998946,"eighty":-2.617416,"marketCap":14371448},{"date":"2024-08-30","current":-1.509387,"twenty":-10.773066,"median":-3.994947,"eighty":-2.608386,"marketCap":12988535},{"date":"2024-09-06","current":-1.430608,"twenty":-10.683068,"median":-3.986949,"eighty":-2.594494,"marketCap":12310636},{"date":"2024-09-13","current":-1.348679,"twenty":-10.679735,"median":-3.974952,"eighty":-2.580885,"marketCap":11605622},{"date":"2024-09-20","current":-1.468422,"twenty":-10.666403,"median":-3.968954,"eighty":-2.564765,"marketCap":12636028},{"date":"2024-09-27","current":-1.361284,"twenty":-10.666403,"median":-3.962955,"eighty":-2.553605,"marketCap":11714086},{"date":"2024-10-04","current":-1.285657,"twenty":-10.666403,"median":-3.951199,"eighty":-2.522682,"marketCap":11063303},{"date":"2024-10-11","current":-1.253642,"twenty":-10.664736,"median":-3.918967,"eighty":-2.456788,"marketCap":10787805},{"date":"2024-10-18","current":-1.279355,"twenty":-10.656402,"median":-3.90541,"eighty":-2.272204,"marketCap":11009071},{"date":"2024-10-25","current":-1.260448,"twenty":-10.649736,"median":-3.886975,"eighty":-2.241517,"marketCap":10846376},{"date":"2024-10-31","current":-1.228937,"twenty":-10.649736,"median":-3.878977,"eighty":-2.213657,"marketCap":10575216},{"date":"2024-11-08","current":-1.329773,"twenty":-10.63307,"median":-3.867021,"eighty":-2.195484,"marketCap":11442926},{"date":"2024-11-15","current":-1.134403,"twenty":-10.63307,"median":-3.838988,"eighty":-2.186447,"marketCap":9761738},{"date":"2024-11-22","current":-0.992954,"twenty":-10.620237,"median":-3.825031,"eighty":-2.17644,"marketCap":9865863},{"date":"2024-11-29","current":-1.031598,"twenty":-10.617915,"median":-3.822992,"eighty":-2.17644,"marketCap":10249825},{"date":"2024-12-06","current":-1.017953,"twenty":-10.603257,"median":-3.799079,"eighty":-2.173186,"marketCap":10114245},{"date":"2024-12-13","current":-0.993773,"twenty":-10.526406,"median":-3.776725,"eighty":-2.165405,"marketCap":9873998},{"date":"2024-12-20","current":-0.9661,"twenty":-10.50394,"median":-3.685321,"eighty":-2.156881,"marketCap":9599042},{"date":"2024-12-27","current":-0.9661,"twenty":-10.501007,"median":-3.673951,"eighty":-2.152499,"marketCap":9599042},{"date":"2025-01-03","current":-0.987933,"twenty":-10.493074,"median":-3.655449,"eighty":-2.140561,"marketCap":9815970},{"date":"2025-01-10","current":-0.960642,"twenty":-10.483074,"median":-3.628872,"eighty":-2.137742,"marketCap":9544810},{"date":"2025-01-17","current":-0.930622,"twenty":-10.482407,"median":-3.599162,"eighty":-2.117676,"marketCap":9246535},{"date":"2025-01-24","current":-0.960642,"twenty":-10.47974,"median":-3.592859,"eighty":-2.093755,"marketCap":9544810},{"date":"2025-01-31","current":-0.979745,"twenty":-10.466407,"median":-3.592669,"eighty":-2.066492,"marketCap":9734622},{"date":"2025-02-07","current":-0.944267,"twenty":-10.466407,"median":-3.576128,"eighty":-2.052861,"marketCap":9382115},{"date":"2025-02-14","current":-0.927893,"twenty":-10.449741,"median":-3.56452,"eighty":-2.028325,"marketCap":9219419},{"date":"2025-02-21","current":-0.971558,"twenty":-10.423075,"median":-3.554752,"eighty":-2.021782,"marketCap":9653274},{"date":"2025-02-28","current":-0.955184,"twenty":-10.410603,"median":-3.548231,"eighty":-1.9967,"marketCap":9490579},{"date":"2025-03-07","current":-0.867852,"twenty":-10.409151,"median":-3.548231,"eighty":-1.9738,"marketCap":8622868},{"date":"2025-03-14","current":-0.851478,"twenty":-10.409151,"median":-3.540945,"eighty":-1.939995,"marketCap":8460173},{"date":"2025-03-21","current":-0.867852,"twenty":-10.396291,"median":-3.530071,"eighty":-1.880017,"marketCap":8622868},{"date":"2025-03-28","current":-0.884227,"twenty":-10.385076,"median":-3.52052,"eighty":-1.837488,"marketCap":8785564},{"date":"2025-04-04","current":-1.065218,"twenty":-10.35641,"median":-3.509535,"eighty":-1.741036,"marketCap":8894028},{"date":"2025-04-11","current":-0.968099,"twenty":-10.336411,"median":-3.49287,"eighty":-1.681873,"marketCap":8083134},{"date":"2025-04-17","current":-0.951801,"twenty":-10.300778,"median":-3.486057,"eighty":-1.655375,"marketCap":7947054},{"date":"2025-04-25","current":-0.968099,"twenty":-10.261546,"median":-3.476509,"eighty":-1.634546,"marketCap":8083134},{"date":"2025-05-02","current":-1.088704,"twenty":-10.220479,"median":-3.458261,"eighty":-1.599871,"marketCap":9090123},{"date":"2025-05-09","current":-1.047959,"twenty":-10.200235,"median":-3.428271,"eighty":-1.571149,"marketCap":8749924},{"date":"2025-05-16","current":-1.030032,"twenty":-10.195047,"median":-3.424319,"eighty":-1.511278,"marketCap":8600237},{"date":"2025-05-23","current":-1.074644,"twenty":-10.166119,"median":-3.379872,"eighty":-1.464927,"marketCap":8872396},{"date":"2025-05-30","current":-1.053217,"twenty":-10.14759,"median":-3.363739,"eighty":-1.423046,"marketCap":8695492},{"date":"2025-06-06","current":-0.995595,"twenty":-10.127255,"median":-3.354932,"eighty":-1.401618,"marketCap":8219758},{"date":"2025-06-13","current":-0.988936,"twenty":-10.093083,"median":-3.345555,"eighty":-1.380191,"marketCap":8164782},{"date":"2025-06-20","current":-0.896635,"twenty":-10.078083,"median":-3.278044,"eighty":-1.362544,"marketCap":7402735},{"date":"2025-06-27","current":-0.936193,"twenty":-10.049188,"median":-3.140759,"eighty":-1.333503,"marketCap":7729326},{"date":"2025-07-03","current":-1.021901,"twenty":-10.013603,"median":-3.098095,"eighty":-1.32347,"marketCap":8436941},{"date":"2025-07-11","current":-0.995529,"twenty":-10.003194,"median":-3.069464,"eighty":-1.291959,"marketCap":8219213},{"date":"2025-07-18","current":-0.962565,"twenty":-9.999753,"median":-3.067588,"eighty":-1.285657,"marketCap":7947054},{"date":"2025-07-25","current":-0.9296,"twenty":-9.997586,"median":-3.061959,"eighty":-1.279355,"marketCap":7674895},{"date":"2025-08-01","current":-0.942786,"twenty":-9.99622,"median":-2.992539,"eighty":-1.26675,"marketCap":7783758},{"date":"2025-08-08","current":-0.591845,"twenty":-9.991419,"median":-2.949387,"eighty":-1.254146,"marketCap":4886349},{"date":"2025-08-15","current":-0.536333,"twenty":-9.983086,"median":-2.906234,"eighty":-1.247844,"marketCap":4428033},{"date":"2025-08-22","current":-0.493527,"twenty":-9.982376,"median":-2.887445,"eighty":-1.228937,"marketCap":5141091},{"date":"2025-08-29","current":-0.491803,"twenty":-9.982376,"median":-2.879932,"eighty":-1.134403,"marketCap":5123128},{"date":"2025-09-05","current":-0.485951,"twenty":-9.962945,"median":-2.868759,"eighty":-1.091051,"marketCap":5062164},{"date":"2025-09-12","current":-0.503978,"twenty":-9.944209,"median":-2.84479,"eighty":-1.075462,"marketCap":5249954},{"date":"2025-09-19","current":-0.621808,"twenty":-9.899103,"median":-2.842923,"eighty":-1.065218,"marketCap":6477393},{"date":"2025-09-26","current":-0.532978,"twenty":-9.888694,"median":-2.81407,"eighty":-1.055693,"marketCap":5552051},{"date":"2025-10-03","current":-0.564173,"twenty":-9.888694,"median":-2.786429,"eighty":-1.046213,"marketCap":5877010},{"date":"2025-10-10","current":-0.689737,"twenty":-9.857811,"median":-2.760639,"eighty":-1.042924,"marketCap":7185008},{"date":"2025-10-17","current":-0.736764,"twenty":-9.7977,"median":-2.75078,"eighty":-1.036955,"marketCap":7674895},{"date":"2025-10-24","current":-0.94055,"twenty":-9.76978,"median":-2.744206,"eighty":-1.031285,"marketCap":9797738},{"date":"2025-10-31","current":-0.658385,"twenty":-9.764242,"median":-2.738753,"eighty":-1.02841,"marketCap":6858416},{"date":"2025-11-07","current":-0.56433,"twenty":-9.755456,"median":-2.734347,"eighty":-1.020136,"marketCap":5878643},{"date":"2025-11-14","current":-0.538203,"twenty":-9.715902,"median":-2.732113,"eighty":-1.015224,"marketCap":5606483},{"date":"2025-11-21","current":-0.500164,"twenty":-9.592783,"median":-2.730396,"eighty":-1.009555,"marketCap":5138883},{"date":"2025-11-28","current":-0.48781,"twenty":-9.509134,"median":-2.727774,"eighty":-1.001913,"marketCap":5011950},{"date":"2025-12-05","current":-0.463949,"twenty":-9.2849,"median":-2.725223,"eighty":-0.994827,"marketCap":4766800},{"date":"2025-12-12","current":-0.609762,"twenty":-9.159949,"median":-2.720996,"eighty":-0.989421,"marketCap":6264937},{"date":"2025-12-19","current":-0.40186,"twenty":-8.847737,"median":-2.713126,"eighty":-0.987933,"marketCap":4128866},{"date":"2025-12-26","current":-0.38309,"twenty":-8.612532,"median":-2.70351,"eighty":-0.982475,"marketCap":3936015},{"date":"2026-01-02","current":-0.339876,"twenty":-8.568813,"median":-2.701482,"eighty":-0.982475,"marketCap":3492021},{"date":"2026-01-09","current":-0.393164,"twenty":-8.550077,"median":-2.698671,"eighty":-0.978142,"marketCap":4039522},{"date":"2026-01-16","current":-0.390301,"twenty":-8.48554,"median":-2.695558,"eighty":-0.977016,"marketCap":4010104},{"date":"2026-01-23","current":-0.463896,"twenty":-8.327321,"median":-2.689555,"eighty":-0.97575,"marketCap":4766255},{"date":"2026-01-30","current":-0.385476,"twenty":-8.168477,"median":-2.688073,"eighty":-0.971901,"marketCap":3960530},{"date":"2026-02-06","current":-0.336854,"twenty":-8.14286,"median":-2.684937,"eighty":-0.971558,"marketCap":3460969},{"date":"2026-02-10","current":-0.30276,"twenty":-8.125044,"median":-2.684937,"eighty":-0.971558,"marketCap":3110677}],"updateTime":1770826073278},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GIPR\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2609151152","title":"Nasdaq Moves to Delist Generation Income Properties Over Equity Rule Violation","url":"https://stock-news.laohu8.com/highlight/detail?id=2609151152","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609151152?lang=en_us&edition=fundamental","pubTime":"2026-02-07 05:10","pubTimestamp":1770412241,"startTime":"0","endTime":"0","summary":"Generation Income Properties Inc. is facing potential delisting from the Nasdaq Capital Market due to failure to meet the minimum stockholders' equity requirement of $2.5 million, as mandated by Nasdaq Listing Rule 5550. The company reported a stockholders' equity deficit of approximately $966,000 as of June 30, 2025, and does not meet alternative compliance standards related to market value or net income. After reviewing the company’s submitted compliance plans, Nasdaq staff denied the request for continued listing, citing a lack of a definitive plan for near-term and sustained compliance. Generation Income Properties Inc. intends to appeal the decision, which will temporarily stay the delisting process pending the outcome of the hearing.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be int","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260206:nNDL7nH8DM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GIPR","BK4160"],"gpt_icon":0},{"id":"2607021518","title":"Nasdaq Warns Generation Income Properties on Minimum Bid Price Compliance","url":"https://stock-news.laohu8.com/highlight/detail?id=2607021518","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607021518?lang=en_us&edition=fundamental","pubTime":"2026-01-31 05:05","pubTimestamp":1769807151,"startTime":"0","endTime":"0","summary":"Generation Income Properties Inc. has received a notice from the Nasdaq Stock Market indicating that its common stock has closed below the minimum $1.00 per share bid price for 35 consecutive business days, putting the company out of compliance with Nasdaq Listing Rule 5550. The company now has a 180-day grace period, until July 6, 2026, to regain compliance by maintaining a closing bid price of at least $1.00 per share for ten consecutive business days. Failure to meet this requirement could lead to a second grace period or possible delisting from the Nasdaq Capital Market. The company is monitoring its stock price and considering options to address the deficiency.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Generation Income Prope","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260130:nNDLSBnSY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4160","GIPR"],"gpt_icon":0},{"id":"1127607481","title":"1+1>2? INSILICO's (03696) GIPR Antagonist Combination Strategy Ignites the Next Weight Loss Trend","url":"https://stock-news.laohu8.com/highlight/detail?id=1127607481","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127607481?lang=en_us&edition=fundamental","pubTime":"2026-01-29 10:12","pubTimestamp":1769652763,"startTime":"0","endTime":"0","summary":"GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) both belong to the incretin hormone family, and their receptor, GIPR, plays a multidimensional, central role in...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GIPR","BK4160","BK1141","03696"],"gpt_icon":0},{"id":"1158406293","title":"ASCLETIS-B (01672) Selects Next-Generation Monthly Subcutaneous GLP-1R/GIPR/GCGR Triple Agonist Peptide ASC37 for Clinical Development","url":"https://stock-news.laohu8.com/highlight/detail?id=1158406293","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158406293?lang=en_us&edition=fundamental","pubTime":"2026-01-20 17:56","pubTimestamp":1768903007,"startTime":"0","endTime":"0","summary":"The Board of ASCLETIS-B (01672) announced that it has selected ASC37, a next-generation, once-monthly, subcutaneously administered GLP-1R/GIPR/GCGR triple agonist peptide, as a clinical development...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01477","BK1515","BK4590","BK1161","BK4160","BK1191","01672","GLP","GIPR","BK1574","BK4144"],"gpt_icon":0},{"id":"2604195420","title":"Ascletis Selects a Next-Generation Once-Monthly Subcutaneously Administered GLP-1R/GIPR/GCGR Triple Peptide Agonist, ASC37, for Clinical Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2604195420","media":"prnewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604195420?lang=en_us&edition=fundamental","pubTime":"2026-01-20 17:00","pubTimestamp":1768899600,"startTime":"0","endTime":"0","summary":"- In head-to-head non-human primate  studies, average observed half-life of ASC37 was approximately 17 days, 7-fold longer than retatrutide, which supports once-monthly subcutaneous  dosing in humans.- ASC37's average in vitro activity was approximately 5-, 4-, and 4-fold more potent than retatrutide for GLP-1R, GIPR and GCGR, respectively.- Submission of an Investigational New Drug Application  to the U.S. Food and Drug Administration  for ASC37 injection is expected in the second quarter of 2026.HONG KONG, Jan. 20, 2026 /PRNewswire/ -- Ascletis Pharma Inc.  announces that it has selected ASC37 injection, a next-generation, once-monthly, subcutaneously administered GLP-1R/GIPR/GCGR[1] triple peptide agonist, as a clinical development candidate. Ascletisexpects to submit an Investigational New Drug Applicationto the U.S. Food and Drug Administrationfor ASC37 injection for the treatment of obesity in the second quarter of 2026.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/ascletis-selects-a-next-generation-once-monthly-subcutaneously-administered-glp-1rgiprgcgr-triple-peptide-agonist-asc37-for-clinical-development-302665199.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IND","BK4160","BK4590","IND.AU","BK4144","BK7095","GIPR","GLP"],"gpt_icon":0},{"id":"2595575371","title":"Generation Income Properties Inc Held Annual Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2595575371","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595575371?lang=en_us&edition=fundamental","pubTime":"2025-12-30 06:05","pubTimestamp":1767045944,"startTime":"0","endTime":"0","summary":"Generation Income Properties Inc held its 2025 Annual Meeting of Stockholders on December 19, 2025. Stockholders elected David Sobelman, Benjamin Adams, Gena Cheng, Stuart Eisenberg, Patrick Quilty, and Richard Russell to the board of directors. The appointment of CohnReznick LLP as the independent registered public accounting firm for fiscal year 2025 was also approved.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Generation Income Properties Inc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 29, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251229:nNDL2Ry3q0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4160","GIPR"],"gpt_icon":0},{"id":"1187203221","title":"ASCLETIS-B (01672) Selects Its First Oral GLP-1R/GIPR/GCGR Triple-Target Agonist Peptide ASC37 for Clinical Development","url":"https://stock-news.laohu8.com/highlight/detail?id=1187203221","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187203221?lang=en_us&edition=fundamental","pubTime":"2025-11-30 18:40","pubTimestamp":1764499221,"startTime":"0","endTime":"0","summary":"ASCLETIS-B (01672) announced that it has selected its first oral GLP-1R/GIPR/GCGR triple-target agonist peptide, ASC37 oral tablets, as a clinical development candidate. The company plans to submit...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4160","01672","BK1574","BK1161","BK1515","GIPR","GLP","BK4144","BK4590","BK1191","01477"],"gpt_icon":0},{"id":"2587618791","title":"Ascletis Selects Its First Oral GLP-1R/GIPR/GCGR Triple Peptide Agonist, ASC37, for Clinical Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2587618791","media":"prnewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2587618791?lang=en_us&edition=fundamental","pubTime":"2025-11-30 18:15","pubTimestamp":1764497700,"startTime":"0","endTime":"0","summary":"- Utilizing Ascletis' Peptide Oral Transport ENhancement Technology , ASC37 oral tablets achieved average absolute oral bioavailability of 4.2%, approximately 9-, 30-, and 60-fold higher than semaglutide, tirzepatide, and retatrutide in the oral SNAC formulation, respectively, in head-to-head non-human primate  studies.- ASC37 oral tablets' drug exposure, as measured by the area under curve , was approximately 57-fold of retatrutide's drug exposure in head-to-head NHP studies.- Average observed half-life of ASC37 oral tablets was approximately 56 hours in NHP studies, supporting once daily and less frequent oral dosing.- ASC37 in vitro activity was approximately 5-, 4- and 4-fold more potent than retatrutide for GLP-1R, GIPR and GCGR, respectively.- Submission of an Investigational New Drug Application  to the U.S. Food and Drug Administration  for ASC37 oral tablets is expected in the second quarter of 2026.\"Selection of ASC37, a promising oral GLP-1R/GIPR/GCGR triple peptide agonist,","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/ascletis-selects-its-first-oral-glp-1rgiprgcgr-triple-peptide-agonist-asc37-for-clinical-development-302628540.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4590","BK4160","IND","IND.AU","BK7104","GLP","GIPR","AUC.AU","BK4144","BK7095"],"gpt_icon":0},{"id":"2584728936","title":"Generation Income Q3 FFO $0.03 Beats $(0.08) Estimate, Sales $2.470M Beat $2.432M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2584728936","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584728936?lang=en_us&edition=fundamental","pubTime":"2025-11-18 05:41","pubTimestamp":1763415706,"startTime":"0","endTime":"0","summary":"Generation Income (NASDAQ:GIPR) reported quarterly earnings of $0.03 per share which beat the analyst consensus estimate of $(0.08) by 137.5 percent. This is a 50 percent increase over earnings of $0.02 per share from","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/11/48912032/generation-income-q3-ffo-0-03-beats-0-08-estimate-sales-2-470m-beat-2-432m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Generation Income Q3 FFO $0.03 Beats $(0.08) Estimate, Sales $2.470M Beat $2.432M Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GIPR","BK4160"],"gpt_icon":0},{"id":"2584108674","title":"Generation Income Properties Reports Q3 2025 Financial and Operating Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2584108674","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584108674?lang=en_us&edition=fundamental","pubTime":"2025-11-18 05:30","pubTimestamp":1763415022,"startTime":"0","endTime":"0","summary":"Generation Income Properties, Inc.  announced its financial and operating results for the third quarter ended September 30, 2025. Approximately 60% of the company's portfolio annualized rent was derived from tenants with an investment grade credit rating of \"BBB-\" or better. The company's largest tenants-General Services Administration, Dollar General, EXP Services, Kohl's Corporation, and the City of San Antonio-accounted for approximately 59% of the portfolio's annualized base rent as of September 30, 2025. Management highlighted ongoing efforts to reposition the portfolio and reduce preferred equity exposure, citing successful asset management strategies. Notably, the company reported the profitable sale of its only vacant property, which was sold at a gain relative to its purchase price from three years prior, despite the property being vacant at the time of sale. The company emphasized the strength of its asset base and the creditworthiness of its tenants as key components of its ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251117:nNDL7bx3G4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1989763690.USD","LU1989763427.SGD","BK4547","BK4220","DG","BK4585","BK4588","LU1430594728.SGD","BK4504","BK4155","LU1585245621.USD","BK4114","BK4103","GIPR","BK4160","KSS"],"gpt_icon":0},{"id":"1162352611","title":"ASCLETIS-B (01672): Monthly-Dose Next-Gen Amylin Receptor Agonist ASC36 and GLP-1R/GIPR Dual-Target Agonist ASC35 Combo Advances to Clinical Development","url":"https://stock-news.laohu8.com/highlight/detail?id=1162352611","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162352611?lang=en_us&edition=fundamental","pubTime":"2025-11-13 07:36","pubTimestamp":1762990584,"startTime":"0","endTime":"0","summary":"ASCLETIS-B (01672) announced that its monthly-dose next-generation amylin receptor agonist ASC36 and GLP-1R/GIPR dual-target agonist ASC35 combination therapy has entered clinical development. The...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLP","01672","BK1515","BK1574","BK4144","BK4590","GIPR","BK1191","BK1161","BK4160","01477"],"gpt_icon":0},{"id":"2583841945","title":"Ascletis Announces Co-formulation of ASC36, Once-Monthly Next-Generation Amylin Receptor Agonist and ASC35, Once-Monthly Next-Generation GLP-1R/GIPR Dual Agonist for Clinical Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2583841945","media":"prnewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583841945?lang=en_us&edition=fundamental","pubTime":"2025-11-13 07:30","pubTimestamp":1762990200,"startTime":"0","endTime":"0","summary":"- Using Ascletis' proprietary Ultra-Long-Acting Platform technology, co-formulation of ASC36, a once-monthly subcutaneously administered amylin receptor peptide agonist and ASC35, a once-monthly subcutaneously administered GLP-1R/GIPR dual peptide agonist, demonstrated a comparable pharmacokinetic  profile to ASC36 and ASC35 dosed alonein head-to-head non-human primate studies.- ASC36 monotherapy demonstrated approximately 32% greater relative body weight reduction compared to eloralintide monotherapy in a head-to-head diet-induced obese  rat study, while ASC35 monotherapy demonstrated approximately 71% greater relative body weight reduction compared to tirzepatide monotherapy in a head-to-head DIO mouse study.- Co-formulation of ASC36 and ASC35 had excellent chemical and physical stability with no aggregation or precipitation caused by fibrillation at neutral pH.HONG KONG, Nov. 13, 2025 /PRNewswire/ -- Ascletis Pharma Inc.  announces the co-formulation of ASC36, a once-monthlynext-gen","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/ascletis-announces-co-formulation-of-asc36-once-monthly-next-generation-amylin-receptor-agonist-and-asc35-once-monthly-next-generation-glp-1rgipr-dual-agonist-for-clinical-development-302613467.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4181","BK4160","IND.AU","BK4218","BK4144","BK7095","GIPR","PK","GLP","BK4590"],"gpt_icon":0},{"id":"2582800511","title":"Press Release: Terns Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Corporate Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2582800511","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582800511?lang=en_us&edition=fundamental","pubTime":"2025-11-11 05:05","pubTimestamp":1762808700,"startTime":"0","endTime":"0","summary":"Unprecedented Phase 1 CML efficacy data and potential best-in-disease profile of TERN-701 featured in ASH 2025 abstract. Upcoming ASH oral presentation to feature expanded and updated dataset from CARDINAL trial. Cash, cash equivalents and marketable securities of $295 million, expected to provide runway into 2028. FOSTER CITY, Calif., Nov. 10, 2025  -- Terns Pharmaceuticals, Inc.  , a clinical-stage oncology company, today reported financial results for the third quarter ended September 30, 2025, and provided corporate updates.TERN-701: Novel investigational allosteric BCR::ABL1 inhibitor for chronic myeloid leukemia . -- In November 2025, Terns announced that an abstract with updated data from. the ongoing Phase 1 CARDINAL trial evaluating TERN-701 in patients with. -- The abstract reported data from the ongoing dose escalation and dose. expansion parts of the CARDINAL trial. Highlights include from the. -- Overall  major molecular response  rate of 75% by. 24 weeks, with 64% achievi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GIPR","BK4007","BK4160","TERN"],"gpt_icon":0},{"id":"2581355832","title":"Generation Income Properties Inc Announces Date for Upcoming Stockholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2581355832","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581355832?lang=en_us&edition=fundamental","pubTime":"2025-11-08 06:16","pubTimestamp":1762553801,"startTime":"0","endTime":"0","summary":"Generation Income Properties Inc. has announced that its 2025 Annual Meeting of Stockholders will be held on December 19, 2025, at Foley & Lardner LLP, 100 North Tampa Street, Suite 2700, Tampa, Florida. During the meeting, management will provide a report on the company's operations and achievements over the past year. Stockholders will also vote on matters presented for approval at the Annual Meeting.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Generation Income Properties Inc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 07, 2025, and is solely responsible for the informa","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251107:nNDL8VPCKN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GIPR","BK4160"],"gpt_icon":0},{"id":"2581808394","title":"Generation Income Properties Sells Vacant Florida Industrial Property for $1.95 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2581808394","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581808394?lang=en_us&edition=fundamental","pubTime":"2025-11-06 06:26","pubTimestamp":1762381579,"startTime":"0","endTime":"0","summary":"Generation Income Properties Inc. has announced the sale of its former Irby Construction-occupied industrial property at 702 Tillman Place in Plant City, Florida. The property, which was vacant at the time of sale, was sold for $1,950,000 in cash.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Generation Income Properties Inc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 05, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251105:nNDL4xQSdG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1261432733.SGD","BK4129","LU1974910355.USD","BK4567","LU2265009873.SGD","LU2023250843.SGD","BK4588","LU1093756168.USD","LU1804176565.USD","LU2023250504.SGD","LU2106854487.HKD","BK4585","LU1093756325.SGD","LU2394011477.USD","GIPR","LU2237438978.USD","PWR","LU1917777945.USD","BK4160"],"gpt_icon":0},{"id":"2580416946","title":"Generation Income Properties Extends Promissory Note Maturity to December 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2580416946","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580416946?lang=en_us&edition=fundamental","pubTime":"2025-11-01 04:31","pubTimestamp":1761942664,"startTime":"0","endTime":"0","summary":"Generation Income Properties Inc. has announced an agreement to extend the maturity date of a secured promissory note with Brown Family Enterprises LLC to December 15, 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Generation Income Properties Inc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on October 31, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251031:nNDL5Fxs2c:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4160","GIPR"],"gpt_icon":0},{"id":"1155542043","title":"Hengrui's Class 1 Innovative Drug HRS-4729, a GLP-1R/GIPR/GCGR Triple Receptor Agonist, Receives Clinical Trial Approval for Metabolic Associated Fatty Liver Disease/Metabolic Associated Steatohepatitis","url":"https://stock-news.laohu8.com/highlight/detail?id=1155542043","media":"Deep News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155542043?lang=en_us&edition=fundamental","pubTime":"2025-09-12 20:01","pubTimestamp":1757678464,"startTime":"0","endTime":"0","summary":"Recently, Hengrui Pharmaceutical and its subsidiary Fujian Shengdi Pharmaceutical Co., Ltd. received the \"Clinical Trial Approval Notice\" issued by the National Medical Products Administration,...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4160","GLP","BK4590","BK1161","06978","GIPR","159992","BK4144","BK1574"],"gpt_icon":0},{"id":"2561400783","title":"Generation Income Properties Inc. Faces Potential Delisting from Nasdaq Due to Non-Compliance with Equity Requirements","url":"https://stock-news.laohu8.com/highlight/detail?id=2561400783","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561400783?lang=en_us&edition=fundamental","pubTime":"2025-08-23 04:26","pubTimestamp":1755894371,"startTime":"0","endTime":"0","summary":"Generation Income Properties Inc. has been notified by The Nasdaq Stock Market LLC that it is not in compliance with the minimum stockholders' equity requirement necessary for continued listing on The Nasdaq Capital Market. The company's reported stockholders' equity deficit of $965,694 falls short of the required $2.5 million. Additionally, it does not meet alternative listing standards, such as having a market value of listed securities of at least $35 million or reporting net income of at least $500,000 in recent fiscal years. The company's stock will continue to trade under the symbol \"GIPR\" while it works to submit a compliance plan by October 3, 2025. If approved, Nasdaq may grant a further 180 days to meet requirements. Failure to comply could lead to a delisting notice, with the company having the option to request a hearing to stay delisting actions.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250822:nNDL6KsTHP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4160","GIPR"],"gpt_icon":0},{"id":"2561195416","title":"David Sobelman, Chairman, President, and CEO, Reports Acquisition of Common Shares in Generation Income Properties Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2561195416","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561195416?lang=en_us&edition=fundamental","pubTime":"2025-08-22 04:32","pubTimestamp":1755808373,"startTime":"0","endTime":"0","summary":"David Sobelman, Chairman, President, and CEO of Generation Income Properties Inc, reported an acquisition of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Generation Income Properties Inc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 21, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250821:nNDL82k9kK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GIPR","BK4160"],"gpt_icon":0},{"id":"2561481188","title":"Generation Income Properties Secures Early Lease Extension with Best Buy, Increasing Rent and Reinforcing Commitment","url":"https://stock-news.laohu8.com/highlight/detail?id=2561481188","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561481188?lang=en_us&edition=fundamental","pubTime":"2025-08-21 04:31","pubTimestamp":1755721882,"startTime":"0","endTime":"0","summary":"Generation Income Properties, Inc.  has announced a successful long-term lease extension with Best Buy Stores, L.P.  at its property in Grand Junction, Colorado. The extension, executed through a Second Amendment to Lease, adds five years to the existing lease, now extending from April 1, 2027, through March 31, 2032. Best Buy has also been granted two additional five-year renewal options. The amendment increases the annual rent to approximately $376,087 starting April 1, 2027, representing a rise from the current rent of about $353,061. This extension underscores Best Buy's commitment to the location and enhances the stability of Generation Income Properties' portfolio, aligning with their investment strategy of maintaining well-located real estate occupied by investment-grade tenants.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250820:nNDL8wPpqr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0942090050.USD","BK4567","BK4533","BK4160","BBY","BK4588","BK4076","BK4585","LU0868494708.USD","GIPR","LU0868494617.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":22,"code":"91000000","status":"200"}]}}